Susquehanna International Group, LLP Wave Life Sciences Ltd. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

23 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$5.12 - $9.01 $354,304 - $623,492	69,200 Added 368.09%	88,000 $721,000
Q2 2024 Aug 15, 2024	SELL	$4.38 - $6.48 $172,134 - $254,664	-39,300 Reduced 67.64%	18,800 $93,000
Q1 2024 May 07, 2024	SELL	$3.54 - $6.84 $34,338 - $66,348	-9,700 Reduced 14.31%	58,100 $358,000
Q4 2023 Feb 14, 2024	BUY	$4.16 - $6.87 $121,888 - $201,291	29,300 Added 76.1%	67,800 $342,000
Q3 2023 Nov 14, 2023	BUY	$3.56 - $5.75 $75,828 - $122,475	21,300 Added 123.84%	38,500 $221,000
Q2 2023 Aug 11, 2023	SELL	$3.51 - $4.69 $98,631 - $131,789	-28,100 Reduced 62.03%	17,200 $62,000
Q1 2023 May 16, 2023	SELL	$3.58 - $6.3 $247,378 - $435,330	-69,100 Reduced 60.4%	45,300 $196,000
Q4 2022 Feb 14, 2023	BUY	$3.18 - $7.0 $284,610 - $626,500	89,500 Added 359.44%	114,400 $800,000
Q3 2022 Nov 14, 2022	BUY	$2.37 - $4.28 $22,041 - $39,804	9,300 Added 59.62%	24,900 $90,000
Q2 2022 Aug 15, 2022	BUY	$1.23 - $3.25 $6,150 - $16,250	5,000 Added 47.17%	15,600 $51,000
Q1 2022 May 16, 2022	SELL	$2.0 - $3.28 $4,600 - $7,544	-2,300 Reduced 17.83%	10,600 $21,000
Q4 2021 Feb 14, 2022	SELL	$3.14 - $5.15 $83,524 - $136,990	-26,600 Reduced 67.34%	12,900 $41,000
Q3 2021 Nov 15, 2021	BUY	$4.89 - $7.12 $26,895 - $39,160	5,500 Added 16.18%	39,500 $194,000
Q2 2021 Aug 11, 2021	SELL	$5.65 - $7.47 $1.48 Million - $1.95 Million	-261,700 Reduced 88.5%	34,000 $226,000
Q1 2021 May 17, 2021	BUY	$5.61 - $12.01 $1.57 Million - $3.35 Million	279,000 Added 1670.66%	295,700 $1.66 Million
Q4 2020 Feb 16, 2021	SELL	$6.99 - $9.26 $343,209 - $454,666	-49,100 Reduced 74.62%	16,700 $131,000
Q3 2020 Nov 16, 2020	BUY	$8.49 - $19.54 $335,355 - $771,830	39,500 Added 150.19%	65,800 $559,000
Q2 2020 Aug 14, 2020	BUY	$7.44 - $11.29 $90,768 - $137,738	12,200 Added 86.52%	26,300 $274,000
Q1 2020 May 15, 2020	SELL	$6.94 - $14.22 $819,614 - $1.68 Million	-118,100 Reduced 89.33%	14,100 $132,000
Q4 2019 Feb 14, 2020	BUY	$7.99 - $37.6 $929,237 - $4.37 Million	116,300 Added 731.45%	132,200 $1.06 Million
Q3 2019 Nov 14, 2019	SELL	$19.17 - $27.4 $116,937 - $167,140	-6,100 Reduced 27.73%	15,900 $326,000
Q2 2019 Aug 14, 2019	SELL	$22.93 - $42.84 $376,052 - $702,576	-16,400 Reduced 42.71%	22,000 $574,000
Q1 2019 May 15, 2019	BUY	$32.69 - $47.91 $1.26 Million - $1.84 Million	38,400 New	38,400 $1.49 Million

Others Institutions Holding WVE

# of Institutions

164

Shares Held

117M

Call Options Held

148K

Put Options Held

109K

Ra Capital Management, L.P. Boston, MA

18.2M
Shares

$249 Million
2.08% of portfolio
Lee Ainslie Maverick Capital LTD | Dallas, Tx

10M
Shares

$137 Million
1.71% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

9.7M
Shares

$133 Million
0.15% of portfolio
Black Rock Inc. New York, NY

6.74M
Shares

$92.1 Million
0.0% of portfolio
M28 Capital Management LP Stamford, CT

6.16M
Shares

$84.3 Million
48.05% of portfolio

View Full List

About Wave Life Sciences Ltd.

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $1.19B
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

More about WVE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account